Drug Discovery Informatics Market Size Worth $2.07 Billion By 2025

The global drug discovery informatics market size was estimated at USD 713.4 million in 2016. It is anticipated to progress at a CAGR of 12.6%

The global Drug Discovery Informatics Market size is expected to reach USD 2.07 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 12.6% during the forecast period. Drug therapy is evolving in response to health care needs of the population. The most recent trend is to develop drugs for treatment of chronic diseases, especially those affecting the older population.

Cardiovascular Diseases (CVDs), stroke, and cancer are the most prevalent health issues and also the most common conditions causing death. Moreover, treatment expenses and costs pertaining to these diseases are very high, which triggers the demand for effective novel molecules. In the U.S. alone, revenue generated through CVD treatments was over USD 444 billion in 2010, and it has been estimated to claim more lives each year than the remaining causes of death combined.

Clinical decision support tools, which include online database for assistance in enhancement of clinical decisions, are timely updated and that significantly impacts market growth. Moreover, the World Health Organization's Consultative Expert Working Group for Research and Development is also involved in evaluation and development of open source drug discovery platforms. Introduction of open drug discovery tool kit (ODDT), which serves as a tool for computer-aided drug discovery by implementing machine learning scoring functions (RF-Score and NN-Score), is anticipated to work in favor of the market.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market

Further key findings from the report suggest:

• Lead generation and lead optimization are anticipated to witness hand-in-hand growth owing to usage of similar IT solutions
• Presence of different co-operation models, such as joint ventures, strategic partnership, price competition, and project selection, for outsourcing drug informatics solutions in the industry is influencing the growth of the market positively
• North America is projected to hold prominent position in the arena throughout the forecast period. Higher incidence rates of different infectious diseases and oncology diseases are expected to drive the demand for informatics solutions to aid drug discovery and development. Presence of molecular R&D laboratories and market players in the U.S. is supplementing the growth of the regional market
• Asia Pacific is likely to post the highest CAGR during the same period, owing to cost saving advantage offered by the region

• Some of the key players operating in the market Boehringer Ingelheim GmBh; ChemAxon; Jubilant Biosys; Certara; Selvita; Novo Informatics; Albany Molecular Research Inc.; Infosys; DiscoverX; Collaborative Drug Discovery Inc; GVK Biosciences; and Charles River Laboratories.